Peptide drug could treat long COVID, prevent reinfection
A new study shows that the drug prevents inflammation and even repairs damaged lung tissue in preclinical models, making it both a prevention and a treatment.
Source: labonline.com.au
Stay updated with breaking news from Berghofer Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study shows that the drug prevents inflammation and even repairs damaged lung tissue in preclinical models, making it both a prevention and a treatment.
A 'supercharged' version of QIMR Berghofer's CMV-specific T cell immunotherapy for brain cancer has advanced to a phase 1 clinical trial with CUREator funding.